Nine Masts Capital’s Medtronic MDT Stock Holding History

Nine Masts Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$77.5K	–	287
2025 Q4	$77.5K	Sell	10,000 -20,000	-67%	-$1.94M	0.01%	74
2025 Q3	$168K	Buy	30,000 +10,000	+50%	+$919K	0.07%	55
2025 Q2	$68K	Buy	20,000 +15,000	+300%	+$1.27M	0.02%	82
2025 Q1	$38.5K	Sell	5,000 -10,000	-67%	-$895K	0.03%	61
2024 Q4	$42.8K	Sell	15,000 -12,500	-45%	-$1.08M	0.01%	153
2024 Q3	$151K	Buy	+27,500	New	+$2.31M	0.07%	89
2018 Q1	–	Hold	0	–	-$40K	–	331
2017 Q4	–	Sell	-800	Closed	-$64.1K	–	180
2017 Q3	$79K	Buy	+800	New	+$66.4K	0.01%	111

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nine Masts Capital's MDT Position: Q3 2025 in Review

Nine Masts Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 7,643 shares — an estimated $703K sold.

Nine Masts Capital first reported a position in MDT in Q3 2017 and held it in 3 quarters. The position peaked at $1.21M in Q4 2024. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Nine Masts Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Nine Masts Capital sold 7,643 Medtronic shares in Q3 2025, an estimated $703K.
Nine Masts Capital first reported a position in Medtronic in Q3 2017 and held it in 3 quarters.
Nine Masts Capital's Medtronic position peaked at $1.21M in Q4 2024.
2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Nine Masts Capital's 13F filing for Q3 2025, filed 13 Nov 2025.